Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. A-a-1 Antibiotic
2. Bi 397
3. Bi-397
4. Bi397
5. Dalbavancin
6. Dalvance
7. Mdl 64,397
8. Mdl-64397
9. Ver-001
10. Ver001
11. Xydalba
12. Zeven
1. Dalbavancin (hydrochloride)
2. Ver 001
3. Ver-001
4. Dalbavancin Hcl
5. Chembl3301650
6. Dalbavancin Hydrochloride (5:8)
7. A-a 1
8. Cs-3579
9. Hy-17586
Molecular Weight | 1853.1 g/mol |
---|---|
Molecular Formula | C88H101Cl3N10O28 |
Hydrogen Bond Donor Count | 22 |
Hydrogen Bond Acceptor Count | 30 |
Rotatable Bond Count | 22 |
Exact Mass | 1850.585236 g/mol |
Monoisotopic Mass | 1850.585236 g/mol |
Topological Polar Surface Area | 573 Ų |
Heavy Atom Count | 129 |
Formal Charge | 0 |
Complexity | 3740 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 18 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J01XA04
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
NDC Package Code : 82297-102
Start Marketing Date : 2016-09-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
Comhony Biotech manufactures fermentation & semi-synthetic APIs which aim at dermatology, anti-biotics; mitochondria & memory health.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6279
Start Marketing Date : 2023-09-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40827
Submission : 2024-12-13
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36025
Submission : 2021-08-25
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-10-25
Pay. Date : 2021-09-14
DMF Number : 35874
Submission : 2021-04-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-01-18
Pay. Date : 2022-12-12
DMF Number : 37186
Submission : 2022-11-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37185
Submission : 2022-09-14
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-07-01
Pay. Date : 2021-05-10
DMF Number : 35428
Submission : 2021-01-04
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-04-23
Pay. Date : 2024-01-29
DMF Number : 39378
Submission : 2024-03-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40827
Submission : 2024-12-13
Status : Active
Type : II
NDC Package Code : 82297-102
Start Marketing Date : 2016-09-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6279
Start Marketing Date : 2023-09-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84688-001
Start Marketing Date : 2024-08-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42513-0017
Start Marketing Date : 2021-01-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
The 5 patients in the age group birth to less than 3 months of age were not included in the efficacy analyses since they were enrolled with expanded inclusion criteria and only received the single-dose DALVANCE regimen.
Lead Product(s): Dalbavancin
Therapeutic Area: Infections and Infectious Diseases Brand Name: Dalvance
Study Phase: Approved FDFProduct Type: Peptide
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 23, 2021
Lead Product(s) : Dalbavancin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
DALVANCE FDA Approval Acute Bacterial Skin Structure Infections in Pediatric
Details : The 5 patients in the age group birth to less than 3 months of age were not included in the efficacy analyses since they were enrolled with expanded inclusion criteria and only received the single-dose DALVANCE regimen.
Product Name : Dalvance
Product Type : Peptide
Upfront Cash : Inapplicable
July 23, 2021
Details:
The antibiotic dalbavancin has strong activity against gram-positive bacteria, including methicillin-resistant S. aureus, which suggests it could be an effective treatment for S. aureus bacteremia. NIH-supported trial will test dalbavancin in hospitalized adults.
Lead Product(s): Dalbavancin
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Peptide
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 27, 2021
Lead Product(s) : Dalbavancin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Trial of Existing Antibiotic for Treating Staphylococcus Aureus Bacteremia Begins
Details : The antibiotic dalbavancin has strong activity against gram-positive bacteria, including methicillin-resistant S. aureus, which suggests it could be an effective treatment for S. aureus bacteremia. NIH-supported trial will test dalbavancin in hospitalize...
Product Name : Undisclosed
Product Type : Peptide
Upfront Cash : Inapplicable
April 27, 2021
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
30
PharmaCompass offers a list of Dalbavancin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dalbavancin manufacturer or Dalbavancin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dalbavancin manufacturer or Dalbavancin supplier.
PharmaCompass also assists you with knowing the Dalbavancin API Price utilized in the formulation of products. Dalbavancin API Price is not always fixed or binding as the Dalbavancin Price is obtained through a variety of data sources. The Dalbavancin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zeven manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zeven, including repackagers and relabelers. The FDA regulates Zeven manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zeven API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zeven manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zeven supplier is an individual or a company that provides Zeven active pharmaceutical ingredient (API) or Zeven finished formulations upon request. The Zeven suppliers may include Zeven API manufacturers, exporters, distributors and traders.
click here to find a list of Zeven suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Zeven DMF (Drug Master File) is a document detailing the whole manufacturing process of Zeven active pharmaceutical ingredient (API) in detail. Different forms of Zeven DMFs exist exist since differing nations have different regulations, such as Zeven USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Zeven DMF submitted to regulatory agencies in the US is known as a USDMF. Zeven USDMF includes data on Zeven's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zeven USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Zeven suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zeven as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zeven API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zeven as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zeven and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zeven NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zeven suppliers with NDC on PharmaCompass.
Zeven Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zeven GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zeven GMP manufacturer or Zeven GMP API supplier for your needs.
A Zeven CoA (Certificate of Analysis) is a formal document that attests to Zeven's compliance with Zeven specifications and serves as a tool for batch-level quality control.
Zeven CoA mostly includes findings from lab analyses of a specific batch. For each Zeven CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zeven may be tested according to a variety of international standards, such as European Pharmacopoeia (Zeven EP), Zeven JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zeven USP).